Feasibility and oncological outcome of patients achieving non-invasive downstaging after transurethral resection of bladder tumor plus systemic chemotherapy for bladder preservation strategy in muscle-invasive bladder cancer

被引:0
|
作者
Onishi, T. [1 ]
Inaba, S. [1 ]
Shibahara, T. [1 ]
Suguno, Y. [2 ]
Inoue, T. [2 ]
Kato, M. [3 ]
Kojima, T. [3 ]
机构
[1] Ise Redcross Hosp, Dept Urol, Ise, Japan
[2] Mie Univ Hosp, Dept Urol, Tsu, Mie, Japan
[3] Aichi Canc Ctr, Dept Urol, Nagoya, Aichi, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A0900
引用
收藏
页码:S1949 / S1950
页数:2
相关论文
共 50 条
  • [1] Feasibility and Oncological Outcome of Patients Achieving Noninvasive Downstaging After Transurethral Resection of Bladder Tumor Plus Systemic Chemotherapy for Bladder Preservation in Muscle-Invasive Bladder Cancer
    Onishi, Takehisa
    Shibahara, Takuji
    Sekito, Sho
    Kato, Manabu
    Sugino, Yusuke
    Inoue, Takahiro
    CLINICAL GENITOURINARY CANCER, 2025, 23 (02)
  • [2] Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer
    Onishi, Takehisa
    Sekito, Sho
    Shibahara, Takuji
    Yabana, Tadashi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 132.e1 - 132.e6
  • [3] Organ preservation for muscle-invasive bladder cancer by transurethral resection
    Leibovici, Dan
    Kassouf, Wassim
    Pisters, Louis L.
    Pettaway, Curtis A.
    Wu, Xifeng
    Dinney, Colin P.
    Grossman, H. Barton
    UROLOGY, 2007, 70 (03) : 473 - 476
  • [4] THE ROLE OF TRANSURETHRAL RESECTION OF BLADDER TUMOR AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
    Asafu-Adjei, Denise
    Lee, Cheryl
    Alva, Ajjai
    Crossley, Heather
    Dailey, Stephen
    Hafez, Khaled
    He, Chang
    Hollenbeck, Brent
    Hussain, Maha
    Montgomery, Jeffrey
    Montie, James
    Morgan, Todd
    Skolarus, Ted
    Smith, David
    Weizer, Alon
    JOURNAL OF UROLOGY, 2014, 191 (04): : E694 - E694
  • [5] PROGNOSIS AFTER RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER DOWNSTAGED BY TRANSURETHRAL RESECTION OF BLADDER TUMOR
    Kim, Kwang Hyun
    You, Dalsan
    Moon, Kyung Hyun
    Ji, Young Hwan
    Jeong, In Gab
    Song, Cheryn
    Hong, Jun Hyuk
    Ahn, Hanjong
    Ahn, Tai Young
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2011, 185 (04): : E197 - E198
  • [6] SIGNIFICANCE OF VISUALLY COMPLETE TRANSURETHRAL RESECTION OF BLADDER TUMOR PRIOR TO NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    Pak, Jamie S.
    Haas, Christopher R.
    Anderson, Christopher B.
    DeCastro, G. Joel
    Benson, Mitchell C.
    McKiernan, James M.
    JOURNAL OF UROLOGY, 2021, 206 : E909 - E909
  • [7] Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation
    Sternberg, Cora N.
    SEMINARS IN ONCOLOGY, 2007, 34 (02) : 122 - 128
  • [8] Effectiveness of transurethral resection (TUR) plus systemic chemotherapy as definitive treatment for muscle-invasive bladder cancer (MIBC)
    Audenet, Francois
    Waingankar, Nikhil
    Ferket, Bart
    Niglio, Scot Anthony
    Marqueen, Kathryn E.
    Mehrazin, Reza
    Sfakianos, John
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [9] ASSOCIATION BETWEEN VISIBLY COMPLETE TRANSURETHRAL RESECTION OF BLADDER TUMOR AND PATHOLOGIC DOWNSTAGING FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
    Baird, Bryce
    Anderson, Augustus
    Ericson, Christian
    Carames, Gianpiero
    Young, Paul
    Lyon, Timothy
    JOURNAL OF UROLOGY, 2022, 207 (05): : E19 - E19
  • [10] BLADDER PRESERVATION BY TRANSURETHRAL RESECTION FOR HIGHLY SELECTED MUSCLE INVASIVE BLADDER CANCER
    Can, C.
    Baseskioglu, B.
    Yenilmez, A.
    Ozen, A.
    Kaya, C.
    Donmez, T.
    Kale, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 544 - 545